DE2344095A1 - Antibakterielle mittel und verfahren zu deren herstellung - Google Patents

Antibakterielle mittel und verfahren zu deren herstellung

Info

Publication number
DE2344095A1
DE2344095A1 DE19732344095 DE2344095A DE2344095A1 DE 2344095 A1 DE2344095 A1 DE 2344095A1 DE 19732344095 DE19732344095 DE 19732344095 DE 2344095 A DE2344095 A DE 2344095A DE 2344095 A1 DE2344095 A1 DE 2344095A1
Authority
DE
Germany
Prior art keywords
sodium
acid
formula
compound
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19732344095
Other languages
German (de)
English (en)
Inventor
Takayuki Naito
Jun Okumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285764A external-priority patent/US3813376A/en
Priority claimed from US00286630A external-priority patent/US3813390A/en
Priority claimed from US00286792A external-priority patent/US3823141A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE2344095A1 publication Critical patent/DE2344095A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19732344095 1972-08-31 1973-08-31 Antibakterielle mittel und verfahren zu deren herstellung Withdrawn DE2344095A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US00285764A US3813376A (en) 1972-08-31 1972-08-31 7-(o-aminomethylphenyl-acetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286630A US3813390A (en) 1972-09-06 1972-09-06 7-(o-aminomethylphenylthioacetamido)-3-(3-hydroxypyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
US00286792A US3823141A (en) 1972-09-06 1972-09-06 7-(o-aminomethyl-p-hydroxy-phenylacetamido)-3-(3-hydroxy-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid

Publications (1)

Publication Number Publication Date
DE2344095A1 true DE2344095A1 (de) 1974-04-18

Family

ID=27403558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732344095 Withdrawn DE2344095A1 (de) 1972-08-31 1973-08-31 Antibakterielle mittel und verfahren zu deren herstellung

Country Status (10)

Country Link
JP (1) JPS5930716B2 (enrdf_load_html_response)
AU (1) AU476592B2 (enrdf_load_html_response)
DE (1) DE2344095A1 (enrdf_load_html_response)
DK (1) DK145465C (enrdf_load_html_response)
ES (1) ES418328A1 (enrdf_load_html_response)
FI (1) FI57420C (enrdf_load_html_response)
FR (1) FR2279408A1 (enrdf_load_html_response)
GB (1) GB1412721A (enrdf_load_html_response)
NL (1) NL7312062A (enrdf_load_html_response)
SE (1) SE415980B (enrdf_load_html_response)

Also Published As

Publication number Publication date
FR2279408B1 (enrdf_load_html_response) 1978-07-28
FI57420C (fi) 1980-08-11
GB1412721A (en) 1975-11-05
FI57420B (fi) 1980-04-30
NL7312062A (enrdf_load_html_response) 1974-03-04
AU476592B2 (en) 1976-09-30
JPS5930716B2 (ja) 1984-07-28
ES418328A1 (es) 1976-09-01
SE415980B (sv) 1980-11-17
DK145465C (da) 1983-04-18
AU5974273A (en) 1975-03-06
FR2279408A1 (fr) 1976-02-20
DK145465B (da) 1982-11-22
JPS4992091A (enrdf_load_html_response) 1974-09-03

Similar Documents

Publication Publication Date Title
DE2461478C2 (de) Cephalosporinderivate und Verfahren zu deren Herstellung
DE2715385C2 (enrdf_load_html_response)
DE2727753C2 (enrdf_load_html_response)
DE2633193A1 (de) Neue, antibakteriell wirksame verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2615693A1 (de) Antibakterielle mittel und verfahren zu ihrer herstellung
DE2524320C2 (de) Cephalosporansäureverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH639666A5 (de) Cephalosporansaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
DE2439880B2 (de) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung
DE2538804C2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Mittel
DE3789720T2 (de) Cephalosporinverbindungen.
DD282691A5 (de) Verfahren zur herstellung von cephalosporin
DE2222434C2 (de) Cephalosporin-Derivat und Verfahren zu dessen Herstellung
DE69030502T2 (de) Cephalosporinverbindungen und deren herstellung
DE2364192A1 (de) Verfahren zur herstellung antibakterieller mittel
DE2700271A1 (de) Thienopyridinderivate
AT391319B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
DE2943437A1 (de) Cephalosporinverbindungen
DE2344095A1 (de) Antibakterielle mittel und verfahren zu deren herstellung
DE2442302C2 (de) Cephalosporine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE3901405A1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung
DE2404592C2 (de) In 3-Stellung thiolierte 7-Acyl-amidocephalosporansäurederivate, Verfahren zu deren Herstellung und sie enthaltende Mittel
DE2309135C2 (de) Cephalosporine und Verfahren zu deren Herstellung
DE2202274C2 (de) 3-Triazolylthiomethyl-cephalosporine und Verfahren zu ihrer Herstellung
DE2818025A1 (de) Verfahren zur herstellung von cephemverbindungen
DD201142A5 (de) Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika

Legal Events

Date Code Title Description
OD Request for examination
8128 New person/name/address of the agent

Representative=s name: KINZEBACH, W., DIPL.-CHEM. DR.PHIL., PAT.-ANW., 80

8139 Disposal/non-payment of the annual fee